Access to post-study medicines: status in Brazil and challenges yet to be overcome.
Pharmaceutical Industry – focused on the future
Descentralized clinical studies
The economic impact of the new health technologies
ANVISA – Post-pandemic challenges and perspectives.
What is the purpose of registration submission guide, based on data from scientific literature?
Clinical research in Brazil - regulation is important and urgent!
Psychedelic Drugs - New Opportunities for the Pharmaceutical Market.
Clinical research in Brazil – New horizons, new challenges
ANVISA has just published the new version of the Cadifa Manual, but what were the main changes?
Medicine patents in Brazil – legislative changes and their impacts.
Brazilian regulation prices, and future trends
Innovation - The Driving Force of the Pharmaceutical Industry
Covid 19 vaccines - know the difference between them
Unraveling the Abbreviated Development Path
Publication of the Public Consultation for the review of RDC 200 - what is new?
NEW REGULATORY FRAMEWORK OF API
Six suggestions for a successful Advisory Board
What is the purpose of clinical research on health products?
Incremental innovations - what are the financial benefits?